any words from CEO
I've sent 2 emails this week and still no asnwer. Does anyone have been able to speak with the CEO ? I think a company update would be welcome from a lot of investors.
- Trial with Bayer ?
- Canadian / USA contract ?
- burn rate ? need a new Private Placement ?
- Exit of insiders (Renaud and Dundee) ? reason why ?
- IR strategy with Arrowhead deployed ? New corporate investors in sight ?
- Revenus forecast still on track ?
We don't hear much from them and most of the time I do not get a reply back from emails.
Communication with investors and IR strategy is AS IMPORTANT AS product for junior companies. YES we have a great product, but without a good IR strategy the word will not spread out, hence more PP, more dilution. SP idle for 12 months (if not negative) .... hard to stay onboard.
Full disclosure : bought in Feb 2017. sold 50% of my shares this Summer at even (0.13).